Axcella Health Inc. (AXLA)
Dec 29, 2023 - AXLA was delisted (reason: company dissolved)
0.4009
0.00 (0.00%)
Inactive · Last trade price on Dec 29, 2023
Axcella Health Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Axcella Health in the last 12 months.
Price Target: n/a
Analyst Consensus: Hold
No price target forecast data available
Analyst Ratings
According to 1 stock analyst, the rating for Axcella Health is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '22 | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 2 | 2 | 1 | 1 | 1 | 0 |
| Hold | 1 | 0 | 0 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 3 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 16, 2023 |
| SVB Leerink | SVB Leerink | Buy → Hold Downgrades $150 → $50 | Buy → Hold | Downgrades | $150 → $50 | +12,371.94% | Dec 16, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 15, 2022 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $175 → $125 | Strong Buy | Maintains | $175 → $125 | +31,079.85% | Nov 2, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $250 | Strong Buy | Maintains | $200 → $250 | +62,259.69% | Oct 3, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.10
from -1.52
EPS Next Year
-5.10
from -5.10
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -5.25 | -5.25 | |
| Avg | -5.10 | -5.10 | |
| Low | -4.90 | -4.90 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.